Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2025 Earnings Call Transcript November 5, 2025
Anika Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.16218 EPS, expectations were $0.02.
Operator: Good morning, ladies and gentlemen, and welcome to Anika’s third quarter earnings conference call. [Operator Instructions] I will now turn the call over to Matt Hall, Director, Corporate Development and Investor Relations. Please proceed.
Matt Hall: Good morning, and thank you for...
